Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Perimenopausal Bone Loss”

Showing 20 of 0 results

Not applicableStudy completedNCT05559619
What this trial is testing

Effect of Laser Acupuncture on Forearm Bone Mineral Density and Wrist Pain in Osteoporotic Postmenopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
Cairo University 68
Early research (Phase 1)Study completedNCT00222872
What this trial is testing

3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women

Who this might be right for
OsteoporosisOsteoporosis, Postmenopausal
University of Pittsburgh 61
Large-scale testing (Phase 3)Study completedNCT02157948
What this trial is testing

Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Amgen 394
Not applicableStudy completedNCT01381588
What this trial is testing

The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women

Who this might be right for
Osteoporosis, Postmenopausal
GlaxoSmithKline 1,136
Early research (Phase 1)Study completedNCT00073190
What this trial is testing

Patient- and Physician-Based Osteoporosis Education

Who this might be right for
OsteoporosisOsteoporosis, Postmenopausal
Brigham and Women's Hospital 30,000
Large-scale testing (Phase 3)Study completedNCT01657162
What this trial is testing

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Radius Health, Inc. 1,139
Post-approval studies (Phase 4)Study completedNCT00079924
What this trial is testing

Effects of Teriparatide in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Osteoporosis
Eli Lilly and Company 200
Post-approval studies (Phase 4)Study completedNCT02808988
What this trial is testing

Changes of GCF Levels of RANKL and Osteoprotegerin in Postmenopausal Osteoporosis

Who this might be right for
Chronic Periodontitis
Ondokuz Mayıs University 47
Large-scale testing (Phase 3)Study completedNCT00718861
What this trial is testing

3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

Who this might be right for
Post-menopausal Osteoporosis
Novartis Pharmaceuticals 190
Large-scale testing (Phase 3)Study completedNCT00481169
What this trial is testing

Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women

Who this might be right for
Osteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer 1,742
Not applicableStudy completedNCT05346419
What this trial is testing

Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients

Who this might be right for
Postmenopausal OsteoporosisHypovitaminosis DHyperparathyroidism
Hospital Regional 1o de Octubre 33
Not applicableLooking for participantsNCT05571514
What this trial is testing

Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis

Who this might be right for
Post Menopausal Osteoporosis
Centre Hospitalier Universitaire de Saint Etienne 200
Large-scale testing (Phase 3)Study completedNCT00092014
What this trial is testing

Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)

Who this might be right for
Postmenopausal Osteoporosis
Organon and Co 1,053
Post-approval studies (Phase 4)UnknownNCT04864509
What this trial is testing

The Effects of Melatonin Treatment on Bone, Marrow, Sleep and Blood Pressure

Who this might be right for
Osteoporosis, Postmenopausal
University of Aarhus 40
Post-approval studies (Phase 4)Study completedNCT01153425
What this trial is testing

ΜMRI of Therapeutic Intervention in Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis, Osteopenia
University of Pennsylvania 33
Large-scale testing (Phase 3)Study completedNCT00463268
What this trial is testing

Osteoporosis Prevention With Low Dose Alendronate

Who this might be right for
Osteopenia
University Hospital of Mont-Godinne 83
Post-approval studies (Phase 4)Active Not RecruitingNCT03623633
What this trial is testing

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis
Massachusetts General Hospital 51
Not applicableStudy completedNCT00696644
What this trial is testing

Teriparatide in Severe Osteoporosis

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis
Eli Lilly and Company 794
Not applicableStudy completedNCT00221312
What this trial is testing

Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss

Who this might be right for
Perimenopausal Bone Loss
University of California, San Francisco 48
Post-approval studies (Phase 4)Study completedNCT00545480
What this trial is testing

SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.

Who this might be right for
Post Menopausal Osteoporosis
Hoffmann-La Roche 596
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation